Cyclooxygenase/lipoxygenase shunting lowers the anti-cancer effect of cyclooxygenase-2 inhibition in colorectal cancer cells

The Cyclooxygenase-2 Inhibitor Etoricoxib Is a Potent Chemopreventive Agent of Colon Carcinogenesis in the Rat Model

(2012) Manpreet Kaur Saini et al.   JOURNAL OF ENVIRONMENTAL PATHOLOGY TOXICOLOGY AND ONCOLOGY

Cycloxygenase-2 is Essential for the Survival and Proliferation of Gastric Cancer Cells

(2011) Dan Ma et al.   CELL BIOCHEMISTRY AND BIOPHYSICS

Role of leukotriene B4 in celecoxib-mediated anticancer effect

(2010) Peng Gao et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Fruit, vegetables, and colorectal cancer risk: the European Prospective Investigation into Cancer and Nutrition

(2009) Fränzel JB van Duijnhoven et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

The anti-proliferative potency of celecoxib is not a class effect of coxibs

(2008) Susanne Schiffmann et al.   BIOCHEMICAL PHARMACOLOGY

Dimethylcelecoxib inhibits prostaglandin E2 production

(2008) Ivonne Wobst et al.   BIOCHEMICAL PHARMACOLOGY

Overexpression of 5-Lipoxygenase in Colon Polyps and Cancer and the Effect of 5-LOX Inhibitors In vitro and in a Murine Model

(2008) L. G. Melstrom et al.   CLINICAL CANCER RESEARCH

Statins and cancer: a meta-analysis of case–control studies

(2008) Marcia L. Taylor et al.   EUROPEAN JOURNAL OF CANCER PREVENTION